Holmes, F A <br/><br/>
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.  [electronic resource] 

 -  Journal of the National Cancer Institute  Dec 1991 
 - 1797-805 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/83.24.1797-a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Agranulocytosis--chemically induced<br/>Alkaloids--adverse effects<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Doxorubicin--therapeutic use<br/>Drug Evaluation<br/>Female<br/>Heart Diseases--chemically induced<br/>Humans<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Muscular Diseases--chemically induced<br/>Paclitaxel<br/>Pain--chemically induced<br/>Peripheral Nervous System Diseases--chemically induced<br/>Remission Induction<br/>Soft Tissue Neoplasms--drug therapy<br/>Thrombocytopenia--chemically induced